Determinants of Urinary Albumin Excretion Reduction in Essential Hypertension: A Long-term Follow-up Study.
From: Hypertension Clinics of Sagunto Hospital, University of Valencia, Spain.
Journal of hypertension
- Publish Date: Nov 2006
- ISSN: 0263-6352
- Volume: 24
- Issue: 11
- Pages: 2277-84
- Medium: Print
- Language: English
- Citation (JAMA): Pascual Jose Maria, Rodilla Enrique, Miralles Amparo, et al. Determinants of Urinary Albumin Excretion Reduction in Essential Hypertension: A Long-term Follow-up Study.. J. Hypertens. Nov 2006;24:2277-84
Abstract
OBJECTIVE: The objective of the present study was to assess factors related to long-term changes in urinary albumin excretion (UAE) of nondiabetic microalbuminuric (n = 252) or proteinuric hypertensive individuals (n = 58) in a prospective follow-up. METHOD: After enrollment, patients were placed on usual care including nonpharmacological treatment and/or treatment with an antihypertensive drug regime to achieve blood pressure < 135/85 mmHg. Periodic UAE measurements were performed until regression or significant reduction (defined when UAE dropped > 50% from the initial values, plus reduction of UAE to < 30 mg/24 h for microalbuminuric patients and < 300 mg/24 h for proteinuric patients). RESULTS: Among the microalbuminuric patients, 113 (44.8%) significantly reduced UAE after a mean follow-up of 18 months (range 12-69 months), 20.3/100 patients per year. Among the proteinuric patients, 29 (50%) significantly reduced UAE after a mean follow-up of 25 months (range 12-51 months), 20.2/100 patients per year. The baseline glomerular filtration rate, diastolic blood pressure and fasting glucose during follow-up were independent factors related to the regression or significant reduction in a Cox proportional hazard model. Regression of UAE was independently related to initial estimated glomerular filtration rate < or = 60 ml/min per 1.73 m (hazard ratio, 0.57; 95% confidence interval, 0.38-0.86; P = 0.001) and DBP > or = 90 mmHg achieved during the follow-up (hazard ratio, 0.57; 95% confidence interval, 0.38-0.86; P = 0.001), even when adjusted for age, gender, body mass index, fasting glucose, presence of treatment at the beginning of the study and treatment with angiotensin-converting enzyme inhibitors or angiotensin receptor blockers during the follow-up. CONCLUSIONS: The reduction of urinary albumin excretion was linked to the preserved glomerular filtration rate and to adequate blood pressure control.
Mesh Headings (Keywords): Adrenergic beta-Antagonists, Adult, Albuminuria, Angiotensin II Type 1 Receptor Blockers, Angiotensin-Converting Enzyme Inhibitors, Blood Pressure, Calcium Channel Blockers, Female, Follow-Up Studies, Glomerular Filtration Rate, Humans, Hypertension, Male, Middle Aged
Check for Full Text / PubMed Unique Identifier (PMID): 17053551
This abstract is part of PubMed, a service of the U.S. National Library of Medicine. PubMed includes more than 17 million citations from MEDLINE and other life science journals for biomedical articles. See Copyright and Disclaimers.
Linked medical terms appearing on this page are added by Healia to help readers find more information and are not part of the original PubMed document.
The data herein was last updated on July 8th, 2008 and may not reflect the most current and accurate data available from NLM.